Should AMA ‘Support’ a Registry to Track Side Effects of GLP-1 Drugs?

(MedPage Today) — CHICAGO — Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse events tied to blockbuster diabetes and weight-loss medications during an open forum at the AMA’s annual…